More Memphasys Ltd news
Memphasys LtdASX: MEM

Felix Trial registration update

Oct 24, 2024 at 12:51 AM EDT · Issued by Memphasys Ltd

Filed with ASX · Oct 24, 2024 at 12:51 AM EDT

On 6ix: 6ix.com/news/felix-trial-registration-update

Memphasys Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Memphasys Ltd on 6ix

In the deck

  • Memphasys — Investor Presentation (October 2024)35 slidesOct 25, 2024

Story so far

  • Felix sales clinical trial and Oxidative Stress devel updateJul 24, 2024
  • Felix Japanese trial provides sperm preparation benefitsMay 20, 2024
  • AI-Port Update - Spring Field Trial Yields Positive ResultsJan 25, 2024

Earlier from Memphasys

  • Equine study commences with 12mth commercialisation expectedOct 17, 2024
  • ProspectusSep 20, 2024
  • Short term loan facilitySep 17, 2024
  • Positive initial study results - Felix equine applicationSep 15, 2024
  • Reinstatement to Official QuotationSep 12, 2024

Later from Memphasys

  • MEM Investor PresentationOct 25, 2024
  • Completion of Placement and SPP offerNov 5, 2024
  • RoXsta System Secures Provisional Patent ApprovalNov 14, 2024
  • Felix Clinical Trial Reaches 95% CompletionNov 17, 2024
  • RoXsta System's Potential in Cattle Breeding being ExploredDec 4, 2024
All Memphasys news releases↗

Follow Memphasys into a list and get an email when it puts out news.

Follow Memphasys
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer